Patients choose this treatment for visible skin quality improvement without adding volume or altering facial structure
But important limitations exist: Most research is in animals, not humans Long-term safety beyond 12 weeks is uncharacterized Drug interactions haven't been formally studied Cancer relationship remains unclear Who should consider BPC-157: Those researching recovery support for injuries or gut issues Individuals willing to accept calculated risk with an experimental peptide People who can work with a knowledgeable healthcare provider Who should avoid it: Those with active cancer or high cancer risk Anyone on medications that might interact (especially cardiovascular, dopamine-affecting) Individuals unwilling to monitor their response carefully If you choose to use BPC-157, start conservatively (200 mcg daily), use proper injection technique, source from reputable suppliers, and track your body's response
Most people receive glutathione injections on a weekly basis, though the frequency can vary based on individual goals and skin type
Krishnan, E., Lessov-Schlaggar, C
Confirm whether consultation fees, provider review fees, or lab work are included or billed separately